Excellent article on patent linkage and evergreening

Patent linkage is a regulatory scheme under which marketing approval of generic drugs isn’t granted until the expiration of original drug’s patent.

Evergreening is a extension of the period of patent protection (or patent linkage) by making use of various laws and regulatory system.

See the article below. It is very informative. It also mentions KORUS FTA.

Australia and New Zealand Health Policy | Abstract | 1743-8462-4-8 | Linkage Pharmaceutical Evergreening in Canada and Australia

Powered by ScribeFire.

Advertisements